Honeywell Intl Inc SEC Filings

Honeywell International (HON) reported an insider equity grant. On 10/13/2025, an officer (President and CEO, IA) received 12,441 employee stock options with a $201.93 exercise price, expiring on 10/12/2035, and 2,352 restricted stock units.

The options vest as follows: 3,110 on 10/13/2026, 3,110 on 10/13/2027, 3,110 on 10/13/2028, and 3,111 on 10/13/2029. The RSUs convert to common stock on a one-for-one basis and vest 776 on 10/13/2027, 776 on 10/13/2028, and 800 on 10/13/2029. Both awards were reported as directly owned.

Honeywell International Inc. (HON) filed a Form 3 to report the initial insider status of an officer listed as President and CEO, IA. The filing states no securities are beneficially owned by the reporting person. The event date is 10/13/2025, and the form was filed by one reporting person.

Honeywell (HON) officer Kenneth J. West reported routine equity activity on Form 4. On 10/02/2025, 950 restricted stock units converted to common stock (code M), and 443 shares were withheld to cover taxes at $211.55 (code F). Two small trades of 3 shares each on 09/18/2025 at $212.41 (A) and 09/23/2025 at $209.63 (D) were noted as broker errors and reversed (code J).

Following these transactions, beneficial ownership was 2,020 shares direct and 611.0189 indirect in a 401(k). RSUs remaining totaled 1,822, with 911 vesting on each of October 2, 2025, 2026, and 2027.

Stephen Williamson, a director of Honeywell International Inc. (HON), reported a grant of 160.5778 deferred compensation (phantom) shares on 10/01/2025. The filing shows a per-share valuation of $210.18 used to calculate the allocation, and reports 676.3872 shares beneficially owned following the transaction. The filing explains these phantom shares are accrued under the company’s Deferred Compensation Plan for Non-Employee Directors and will be settled in cash according to the director’s election.

Honeywell sold Sterling Wander, the entity holding certain legacy asbestos liabilities, to Delticus in a transaction that moved those liabilities and related insurance assets off Honeywell's consolidated balance sheet. At closing, Sterling Wander was capitalized with the insurance assets and approximately $1.68 billion in cash, and Delticus assumed management of claims and insurance policy reimbursements.

A solvency opinion from an independent advisory firm supported the determination that Sterling Wander and its subsidiaries were solvent and adequately capitalized as of and after the Divestiture. Honeywell furnished a press release announcing the transaction as an exhibit to its report. The filing also includes standard forward-looking statement disclosures and notes material risks and uncertainties related to future strategic actions.

Honeywell announced key steps for the separation of its Advanced Materials business into a new public company, Solstice Advanced Materials Inc. The company set a record date of October 17, 2025 for a pro rata distribution expected to be effective at 12:01 a.m. on October 30, 2025, with eligible Honeywell holders to receive one share of Solstice for every four Honeywell shares held on the record date. The Form 10 for Solstice was declared effective by the SEC on September 30, 2025.

Solstice issued $1.0 billion of 5.625% Senior Notes due 2033 on September 30, 2025. The notes were sold under Rule 144A and Regulation S, will pay interest semiannually on March 31 and September 30 beginning March 31, 2026, and proceeds will be held in escrow until spin-off conditions are satisfied. If conditions are not met by March 31, 2026, the notes will be redeemed at 100% of principal plus accrued interest. The indenture contains customary covenants limiting additional debt, dividends, asset sales, liens, and certain transactions with affiliates.

This Form 4 for Honeywell International Inc. (HON) discloses that Lucian Boldea is no longer an officer of the company for purposes of Rule 16a-1. The form lists a transaction date of 08/31/2025 and is signed by Richard Kent on 09/02/2025. No non-derivative or derivative securities trades, amounts, or prices are reported on this filing; the form was filed solely to report the change in officer status.

Lucian Boldea, President and CEO, IA of Honeywell International Inc. (HON), reported multiple stock option exercises and open-market sales on 08/27/2025. He exercised 17,594 options at $171.73, 11,903 options at $199.60, and 6,684 options at $197.68 to acquire the same number of common shares. On the same date he sold matching amounts: 17,594 shares at a weighted-average price of $221.6036, 11,903 shares at $221.6036, 6,684 shares at $221.6036, and an additional 5,968 shares at $221.4404. Following these transactions, the reporting person beneficially owned 16,302 shares directly, with an additional 259.1954 indicated as held indirectly in a 401(k) plan.

The Form 4 lists the exercised options' original grant details and vesting schedules and discloses that the reported sale prices were executed in multiple transactions (range noted in footnote). These are routine officer option exercises and subsequent share sales reported under Section 16.

Form 144 filed for Honeywell International (HON) discloses a proposed sale of 5,968 shares of common stock through J.P. Morgan Securities LLC with an aggregate market value of $1,328,238. The filing names NASDAQ as the exchange and indicates an approximate sale date of 08/27/2025. The shares were acquired via multiple RSU vest events on dates including 10/17/2022, 10/03/2023, 12/04/2023, 03/18/2024 and 06/10/2024. The filer certifies no undisclosed material information and states there were no sales in the past three months by the reporting person.